Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith Updates

Toinv

Jan 29, 2016 10:52AM

Jan 29, 2016 12:50PM

Jan 30, 2016 10:49AM

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Updates

in response to

Re: Zenith Updates

KayakerBC

posted on Jan 30, 2016 11:14AM

And, with a successful IND and a Phase I about to start, the company is in a much stronger position to negotiate. Contrast that with 2014 when the company suspended clinical development of ZEN-3365.

5 Recommendations

Jan 30, 2016 01:05PM

Feb 02, 2016 02:53PM

masila

Feb 02, 2016 07:02PM

Re: Zenith Updates

chicagoest